Here are five points:
1. During Q3, the firm sold 250,000 AmSurg shares.
2. AmSurg comprises nearly 4.1 percent of Stonerise Capital Management’s portfolio.
3. As of it most recent filing with the U.S. Securities and Exchange Commission, Stonerise Capital Management owned 0.13 percent of AmSurg.
4. On Feb. 8, 2017, AmSurg shares increased 0.7 percent, reaching $69.02.
5. AmSurg’s market cap totals $3.71 billion.
More articles on surgery centers:
12 thoughts for surgery centers – 2017
Analysts give SCA shares ‘hold’ rating — 4 notes
BelHealth Investment Partners acquires American HealthCare Staffing Association — 5 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
